Cargando…

Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides

OBJECTIVE: To assess the impact of immunosuppressive therapy with cyclophosphamide (CYC) and rituximab (RTX) on serum immunoglobulin (Ig) concentrations and B lymphocyte counts in patients with ANCA-associated vasculitides (AAVs). METHODS: Retrospective analysis of Ig concentrations and peripheral B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venhoff, Nils, Effelsberg, Nora M., Salzer, Ulrich, Warnatz, Klaus, Peter, Hans Hartmut, Lebrecht, Dirk, Schlesier, Michael, Voll, Reinhard E., Thiel, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357389/ https://www.ncbi.nlm.nih.gov/pubmed/22629432 http://dx.doi.org/10.1371/journal.pone.0037626

Ejemplares similares

B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide
por: Thiel, Jens, et al.
Publicado: (2011)

B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients
por: Thiel, Jens, et al.
Publicado: (2017)

Blood CD3-(CD56 or 16)+ natural killer cell distributions are heterogeneous in healthy adults and suppressed by azathioprine in patients with ANCA-associated vasculitides
por: Merkt, Wolfgang, et al.
Publicado: (2021)

Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides
por: Giaglis, Stavros, et al.
Publicado: (2023)

Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
por: Thiel, Jens, et al.
Publicado: (2013)

ANCA-associated vasculitides in childhood
por: Garan, Diána, et al.
Publicado: (2011)

Overlap between dermatomyositis and ANCA vasculitides
por: Yuste, Claudia, et al.
Publicado: (2014)

CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1
por: Zeisbrich, Markus, et al.
Publicado: (2021)

Favourable outcome of acute hepatitis E infection in patients with ANCA-associated vasculitis
por: Zeisbrich, Markus, et al.
Publicado: (2022)

French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
por: Terrier, Benjamin, et al.
Publicado: (2020)

Correction to: French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
por: Terrier, Benjamin, et al.
Publicado: (2021)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
por: Cortazar, Frank B., et al.
Publicado: (2017)

T-helper cells as new players in ANCA-associated vasculitides
por: Abdulahad, Wayel H, et al.
Publicado: (2011)

Development of an ANCA-Associated Vasculitides Patient Registry in Greece
por: Thomas, Konstantinos, et al.
Publicado: (2020)

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy
por: Novikov, Pavel, et al.
Publicado: (2016)

Interest of Procalcitonin in ANCA Vasculitides for Differentiation between Flare and Infections
por: Poirot-Seynaeve, Xavier, et al.
Publicado: (2023)

Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides
por: Bonaci-Nikolic, Branka, et al.
Publicado: (2005)

Plasma levels of M-CSF are increased in ANCA-associated vasculitides with active nephritis
por: Ramirez, Giuseppe A., et al.
Publicado: (2015)

T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides
por: Greulich, Simon, et al.
Publicado: (2017)

A rare case of spontaneous renal rupture caused by ANCA - associated vasculitides
por: Yu, Yongquan, et al.
Publicado: (2018)

ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives
por: Folci, Marco, et al.
Publicado: (2019)

Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?
por: Toyoda, Task, et al.
Publicado: (2022)

Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity
por: Solans-Laqué, Roser, et al.
Publicado: (2017)

The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral Involvement
por: Venhoff, Nils, et al.
Publicado: (2019)

Development of Canadian Recommendations for the Management of ANCA-Associated Vasculitides: Results of the National Needs Assessment Questionnaire
por: Famorca, Leilani, et al.
Publicado: (2015)

CanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides – Executive summary
por: McGeoch, Lucy, et al.
Publicado: (2015)

Genetic loci of Staphylococcus aureus associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides
por: Glasner, Corinna, et al.
Publicado: (2017)

Vasculitides
por: Weyand, Cornelia M., et al.
Publicado: (2008)

Analysis of Specific IgG Titers Against Tick-Borne Encephalitis in Patients with Primary Antibody Deficiency Under Immunoglobulin Substitution Therapy: Impact of Plasma Donor Origin
por: Goldacker, Sigune, et al.
Publicado: (2015)

Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV)
por: Manojlovic, M., et al.
Publicado: (2020)

Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides
por: Roubille, Camille, et al.
Publicado: (2021)

Circulating mitochondrial DNA copy numbers represent a sensitive marker for diagnosis and monitoring of disease activity in systemic lupus erythematosus
por: Giaglis, Stavros, et al.
Publicado: (2021)

COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis
por: Schramm, Markus A., et al.
Publicado: (2020)

Case Report: Effective and Safe Treatment With Certolizumab Pegol in Pregnant Patients With Cogan’s Syndrome: A Report of Three Pregnancies in Two Patients
por: Venhoff, Nils, et al.
Publicado: (2021)

Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report
por: Baird, Emily M, et al.
Publicado: (2011)

Serum calprotectin and renal function decline in ANCA-associated vasculitides: a post hoc analysis of MAINRITSAN trial
por: Romand, Xavier, et al.
Publicado: (2023)

Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis
por: Frede, Natalie, et al.
Publicado: (2022)

Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy
por: Venhoff, Nils, et al.
Publicado: (2012)

Vasculitides in HIV Infection
por: Vega, Luis E., et al.
Publicado: (2020)

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0re5rushc5931eae7lq0aa368b